Bio-Hermes Clinical Trial Launches to Compare Biomarker Tests;
Seeks Rapid, Less Expensive Diagnostics for Alzheimer’s Disease Lilly, AbbVie, Merck, the Alzheimer’s Drug Discovery Foundation, and...
Bio-Hermes Clinical Trial Launches to Compare Biomarker Tests;
Bio-Hermes: Making Alzheimer’s Diagnosis Fast, Cheap, Accessible
Israeli duo’s early Alzheimer’s detection test brings cure one step closer
Gentex partners with RetiSpec on Alzheimer’s disease detection technology
Feast Your Eyes on this New Technology for Early Alzheimer's Screening
RetiSpec Receives Award from Alzheimer's Drug Discovery Foundation (ADDF)
RetiSpec Announces Partnership With Gentex To Commercialize Alzheimer's Disease Detection Technology
An Eye Scan For Alzheimer's? Toronto Memory Program is Looking Into It (CTV NEWS)
CABHI is working with RetiSpec to accelerate its technology in Ontario and Canada
University of Minnesota collaborates with medical imaging startup RetiSpec
From the Lab to Life: A Retinal Scanner for Early Detection of Alzheimer’s Disease